CIBC Private Wealth Group
TARS icon

CIBC Private Wealth Group’s Tarsus Pharmaceuticals TARS Stock Holding History

CIBC Private Wealth Group’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$205K Buy
+2,500
New +$187K ﹤0.01% 1177

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

CIBC Private Wealth Group's TARS Position: Q4 2025 in Review

CIBC Private Wealth Group opened a new position in Tarsus Pharmaceuticals (TARS) in Q4 2025: 2,500 shares worth $205K. The stake represents ﹤0.01% of the portfolio and ranks #1177 among its holdings.

246 funds tracked by Wall St. Rank hold TARS as of Q4 2025.

  • CIBC Private Wealth Group held 2,500 shares of Tarsus Pharmaceuticals worth $205K as of Q4 2025.
  • Tarsus Pharmaceuticals was a new CIBC Private Wealth Group position in Q4 2025.
  • Tarsus Pharmaceuticals made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #1177 holding.
  • 246 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.